Literature DB >> 18973589

Differential changes in axonal conduction following CNS demyelination in two mouse models.

Yoshio Bando1, Kaoru Takakusaki, Shinji Ito, Ryuji Terayama, Makoto Kashiwayanagi, Shigetaka Yoshida.   

Abstract

Transgenic and disease model mice have been used to investigate the molecular mechanisms of demyelinating diseases. However, less attention has been given to elucidating changes in nerve conduction in these mice. We established an experimental system to measure the response latency of cortical neurons and examined changes in nerve conduction in cuprizone-induced demyelinating mice and in myelin basic protein-deficient shiverer mice. Stimulating and recording electrodes were placed in the right and left sensori-motor cortices, respectively. Electrical stimulation of the right cortex evoked antidromic responses in left cortical neurons with a latency of 9.38 +/- 0.31 ms (n = 107; mean +/- SEM). While response latency was longer in mice at 7 days and 4 weeks of cuprizone treatment (12.35 +/- 0.35 ms, n = 102; 11.72 +/- 0.29 ms, n = 103, respectively), response latency at 7 days and 4 weeks after removal of cuprizone was partially restored (10.72 +/- 0.45 ms, n = 106; 10.27 +/- 0.34 ms, n = 107, respectively). Likewise, electron microscopy showed cuprizone-induced demyelination in the corpus callosum and nearly complete remyelination after cuprizone removal. We also examined whether the myelin abnormalities in shiverer mice affected their response latencies. But there were no significant differences in response latencies in shiverer (9.83 +/- 0.24 ms, n = 103) and wild-type (9.33 +/- 0.22 ms, n = 112) mice. The results of these electrophysiological assessments imply that different demyelinating mechanisms, differentially affecting axon conduction, are present in the cuprizone-treated and shiverer mice, and may provide new insights to understanding the pathophysiology of demyelination in animal models in the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973589     DOI: 10.1111/j.1460-9568.2008.06474.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

Review 2.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

Review 3.  Models for Studying Myelination, Demyelination and Remyelination.

Authors:  I Osorio-Querejeta; M Sáenz-Cuesta; M Muñoz-Culla; D Otaegui
Journal:  Neuromolecular Med       Date:  2017-05-23       Impact factor: 3.843

Review 4.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

5.  Dysmyelination of auditory afferent axons increases the jitter of action potential timing during high-frequency firing.

Authors:  Jun Hee Kim; Robert Renden; Henrique von Gersdorff
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

6.  The impact of myelination on axon sparing and locomotor function recovery in spinal cord injury assessed using diffusion tensor imaging.

Authors:  Tsang-Wei Tu; Joong H Kim; Feng Qin Yin; Lyn B Jakeman; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2013-06-18       Impact factor: 4.044

7.  Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.

Authors:  Heba R Ghaiad; Mohammed M Nooh; Maha M El-Sawalhi; Amira A Shaheen
Journal:  Mol Neurobiol       Date:  2016-04-11       Impact factor: 5.590

8.  Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.

Authors:  C Guglielmetti; J Veraart; E Roelant; Z Mai; J Daans; J Van Audekerke; M Naeyaert; G Vanhoutte; R Delgado Y Palacios; J Praet; E Fieremans; P Ponsaerts; J Sijbers; A Van der Linden; M Verhoye
Journal:  Neuroimage       Date:  2015-10-23       Impact factor: 6.556

Review 9.  A putative functional role for oligodendrocytes in mood regulation.

Authors:  N Edgar; E Sibille
Journal:  Transl Psychiatry       Date:  2012-05-01       Impact factor: 6.222

10.  Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.

Authors:  Amany El-Shahawy Abdel-Maged; Amany M Gad; Laila Ahmed Rashed; Samar S Azab; Eman A Mohamed; Azza S Awad
Journal:  Mol Neurobiol       Date:  2020-06-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.